Wellstar International, Inc./TMI Imaging System Being Utilized in Breast Cancer Study at Duke University Medical Center

HOLLAND, OH--(Marketwire - November 21, 2008) - Wellstar International, Inc. (OTCBB: WLSI), a provider of specialized diagnostic software and equipment, announced today that the Department of Radiation Oncology at Duke University Medical Center (DUMC) has disclosed its utilization of the Trillenium Medical Imaging system ("TMI") to validate the system's potential to measure the clinical response rates to novel therapies indicated in recurrent breast cancer patients.

Back to news